Press Releases Roche Holding AG Swiss Exchange

Equities

Market Closed - Swiss Exchange Other stock markets 11:31:05 2026-05-13 am EDT			5-day change	1st Jan Change
320.00 ^CHF	-0.47%		-0.59%	-2.50%

May. 13	US FDA approves BeOne's drug for a type of blood cancer	RE
May. 13	Roche Holding AG - Analyst/Investor Day

Apr. 30	Genentech to Present Extensive Data Showcasing Its Industry-Leading Ophthalmology Portfolio at ARVO 2026	BU
Apr. 24	Genentech Partners With Comedy Icon Damon Wayans and diaTribe to Address Diabetes-Related Vision Loss With ‘All Eyes on DME’ Campaign	BU
Apr. 22	Roche's ENSPRYNG (satralizumab) reduces risk of relapses by 68% demonstrating potential to become first treatment for MOGAD	AQ
Apr. 21	Genentech’s Fenebrutinib Significantly Reduced Relapses Versus Standard of Care to Approximately One Every 17 Years in RMS	BU
Apr. 21	Genentech’s Enspryng (Satralizumab) Reduces Risk of Relapses by 68% Demonstrating Potential to Become First Treatment for MOGAD	BU
Apr. 21	CORRECTING and REPLACING FDA Accepts Application for Genentech’s Gazyva for the Treatment of the Most Common Form of Lupus	BU